Jagsonpal Pharmaceuticals Limited — Others, 23-10-2024: Amendment to AOA/MOA

Jagsonpal Pharmaceuticals Limited announced that its Board of Directors approved the unaudited financial results for the quarter and half-year ended September 30, 2024. Additionally, the company will seek postal ballot approval for a share split, converting each equity share from Rs. 5 to Rs. 2 face value to improve liquidity and make shares more accessible for small investors. The record date for the share split will be determined post-approval.